These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7030942)

  • 41. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunopathology of leprosy].
    Bottasso OA; Morini JC
    Medicina (B Aires); 1989; 49(3):210-2. PubMed ID: 2487413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin test response to M. leprae precursor coccoid organisms in a high leprosy endemic area as compared to lepromin.
    Chatterjee BR
    Lepr India; 1981 Oct; 53(4):566-79. PubMed ID: 7038299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Early reaction (Fernandez) in children and adolescents without contact or manifestations of leprosy, tested with human lepromin and different concentrations of armadillo antigens in 3 double-blind studies].
    Bechelli LM; Haddad N; Guimaraes Pagnano PM; Garrido Neves R; Melchior E; Carminatti Fregnan R
    Acta Leprol; 1979; (76-77):181-90. PubMed ID: 121833
    [No Abstract]   [Full Text] [Related]  

  • 46. Vaccine trials against leprosy.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):587-9. PubMed ID: 10347583
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of Dharmendra antigen.
    Sengupta U; Ramu G; Desikan KV
    Lepr India; 1978 Oct; 50(4):599-609. PubMed ID: 374878
    [No Abstract]   [Full Text] [Related]  

  • 48. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine.
    Mistry NF; Antia NH
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):110-3. PubMed ID: 2659695
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immunopathology of erythema nodosum leprosum: the role of extravascular complexes.
    Ridley MJ; Ridley DS
    Lepr Rev; 1983 Jun; 54(2):95-107. PubMed ID: 6350778
    [No Abstract]   [Full Text] [Related]  

  • 51. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
    Chen ZL; Tang QG; Wang ZM; Chen J
    Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of immune reactions in leprosy.
    Harboe M
    Ethiop Med J; 1976 Oct; 14(4):205-12. PubMed ID: 799966
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
    David HL; Maroja M F; Cruaud P
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
    [No Abstract]   [Full Text] [Related]  

  • 54. Skin test activity of an antigen fraction prepared from Mycobacterium leprae compared with standard lepromin and tuberculin PPD in leprosy patients.
    Reitan LJ; Touw-Langendijk EM; Closs O; Belehu A
    Lepr Rev; 1984 Mar; 55(1):33-40. PubMed ID: 6369055
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
    Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
    Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria.
    Mustafa AS; Talwar GP
    Lepr India; 1978 Oct; 50(4):566-71. PubMed ID: 374875
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
    Gill HK; Mustafa AS; Godal T
    Bull World Health Organ; 1986; 64(1):121-6. PubMed ID: 3524883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary study of a Mycobacterium leprae bacterin vaccine in a human volunteer population in a nonendemic area.
    Millikan LE; Krotoski WA; Mroczkowski TF; Douglas JT; Courrege ML
    Int J Dermatol; 1986 May; 25(4):245-8. PubMed ID: 3519481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.